These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 28029170)

  • 41. The histone deacetylase inhibitor sodium butyrate decreases excessive ethanol intake in dependent animals.
    Simon-O'Brien E; Alaux-Cantin S; Warnault V; Buttolo R; Naassila M; Vilpoux C
    Addict Biol; 2015 Jul; 20(4):676-89. PubMed ID: 25041570
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recovery from alcohol dependence: Do smoking indicators predict abstinence?
    Hufnagel A; Frick U; Ridinger M; Wodarz N
    Am J Addict; 2017 Jun; 26(4):366-373. PubMed ID: 28376287
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Class I-Specific HDAC Inhibitor MS-275 Decreases Motivation to Consume Alcohol and Relapse in Heavy Drinking Rats.
    Jeanblanc J; Lemoine S; Jeanblanc V; Alaux-Cantin S; Naassila M
    Int J Neuropsychopharmacol; 2015 Mar; 18(9):. PubMed ID: 25762717
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Applications of relapse prevention with moderation goals.
    Larimer ME; Marlatt GA
    J Psychoactive Drugs; 1990; 22(2):189-95. PubMed ID: 2197393
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Excessive ethanol drinking following a history of dependence: animal model of allostasis.
    Roberts AJ; Heyser CJ; Cole M; Griffin P; Koob GF
    Neuropsychopharmacology; 2000 Jun; 22(6):581-94. PubMed ID: 10788758
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The GABA
    Augier E; Dulman RS; Damadzic R; Pilling A; Hamilton JP; Heilig M
    Neuropsychopharmacology; 2017 Aug; 42(9):1789-1799. PubMed ID: 28294133
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Liver transplantation and alcoholic liver disease: History, controversies, and considerations.
    Marroni CA; Fleck AM; Fernandes SA; Galant LH; Mucenic M; de Mattos Meine MH; Mariante-Neto G; Brandão ABM
    World J Gastroenterol; 2018 Jul; 24(26):2785-2805. PubMed ID: 30018475
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A clinical review of alcohol, alcoholism, and the elderly patient.
    Schuckit MA
    J Clin Psychiatry; 1982 Oct; 43(10):396-9. PubMed ID: 6749825
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of N-acetylcysteine on alcohol abstinence and alcohol-induced adverse effects in rats.
    Ferreira Seiva FR; Amauchi JF; Ribeiro Rocha KK; Souza GA; Ebaid GX; Burneiko RM; Novelli EL
    Alcohol; 2009 Mar; 43(2):127-35. PubMed ID: 19251114
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regional brain volume changes in alcohol-dependent individuals during early abstinence: associations with relapse following treatment.
    Durazzo TC; Mon A; Gazdzinski S; Meyerhoff DJ
    Addict Biol; 2017 Sep; 22(5):1416-1425. PubMed ID: 27329647
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alcohol relapse induced by discrete cues activates components of AP-1 transcription factor and ERK pathway in the rat basolateral and central amygdala.
    Radwanska K; Wrobel E; Korkosz A; Rogowski A; Kostowski W; Bienkowski P; Kaczmarek L
    Neuropsychopharmacology; 2008 Jul; 33(8):1835-46. PubMed ID: 17851539
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Which relapse criteria best predict the mortality risk of treated alcoholics?
    Yoshino A; Kato M; Yoshimasu H; Tatsuzawa Y; Watanabe T
    Alcohol Clin Exp Res; 1997 Nov; 21(8):1374-8. PubMed ID: 9394107
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The meaning of the alcoholic relapse].
    Archambault JC
    Acta Psychiatr Belg; 1985; 85():697-702. PubMed ID: 4096255
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Models of chronic alcohol exposure and dependence.
    Knapp DJ; Breese GR
    Methods Mol Biol; 2012; 829():205-30. PubMed ID: 22231816
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Counting the cold ones: A comparison of methods measuring total alcohol consumption of managed alcohol program participants.
    Chow C; Wettlaufer A; Zhao J; Stockwell T; Pauly BB; Vallance K
    Drug Alcohol Rev; 2018 Apr; 37 Suppl 1():S167-S173. PubMed ID: 29266461
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Taxonomy of high-risk situations for alcohol relapse: evolution and development of a cognitive-behavioral model.
    Marlatt GA
    Addiction; 1996 Dec; 91 Suppl():S37-49. PubMed ID: 8997780
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of DA-Phen, a dopamine-aminoacidic conjugate, on alcohol intake and forced abstinence.
    Sutera FM; De Caro V; Cannizzaro C; Giannola LI; Lavanco G; Plescia F
    Behav Brain Res; 2016 Sep; 310():109-18. PubMed ID: 27155501
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hyper-oligodendrogenesis at the vascular niche and reduced blood-brain barrier integrity in the prefrontal cortex during protracted abstinence.
    Somkuwar SS; Fannon MJ; Bao Nguyen T; Mandyam CD
    Neuroscience; 2017 Oct; 362():265-271. PubMed ID: 28870701
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Decision Making in Alcoholic Patients and Its Contribution to Relapse.
    Duka T
    Biol Psychiatry; 2017 Dec; 82(11):779-780. PubMed ID: 29110818
    [No Abstract]   [Full Text] [Related]  

  • 60. On Abstinence from Drinks in the Treatment of Some Diseases.
    Ill Indiana Med Surg J; 1846 Apr; 1(1):83. PubMed ID: 37262498
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.